MM&M Awards: A Message From the Editor

This year's Award winners show what good looks like in a host of pharma marketing areas, including new categories like immersive technology and orphan product initiative.

Marc Iskowitz

October 20, 2017

2:00 am

Welcome to this special showcase of the winning work from the 2017 MM&M Awards.

The objective of the MM&M Awards program, now in its 14th year, is to recognize and champion both creativity and effectiveness in healthcare marketing and communications. Several new categories have been added to showcase top work and talent. Yet we remain committed to ensuring that pharma-sponsored branded projects — the kind that face many regulatory barriers — get reviewed against similar work, and celebrated if deemed worthy.

These awards are further distinguished by the level of independence and authority with which each submission is reviewed. A panel of more than 100 of the sharpest minds and talent — representing a wide variety of disciplines and backgrounds in healthcare marketing — reviewed and scored the nearly 700 entries we received. Judging the MM&M Awards, which takes place in an online round followed by a live one-day event, is a significant undertaking. So I’d like to thank all of our 2017 judges for their valuable efforts.

I would also like to thank our sponsors. By recognizing the importance of our awards through their support, they have enabled us to continue to make this program bigger and better every year.

Finally, I’d like to congratulate all our finalists and winners. We have taken every possible measure to ensure that the best work wins. And even if you were unsuccessful this time around, I hope you enjoy a fabulous evening with colleagues and peers at the biggest and best party in the industry. Thank you for being part of the 2017 MM&M Awards. We hope to see you again next year.